Clinical Trials Logo

Typhoid clinical trials

View clinical trials related to Typhoid.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03933098 Active, not recruiting - Typhoid Clinical Trials

Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine

Start date: November 15, 2019
Phase: Phase 3
Study type: Interventional

This is a Multicenter, observer-blinded, randomized, Active controlled, Phase 3 study in healthy 6 months to 45 years aged Nepalese at the time of the first vaccine dose. The study objectives are: I. Demonstrate non-inferiority of Vi-DT compared to Typbar TCV® as measured by seroconversion rates of anti-Vi IgG ELISA antibody titers, 4 weeks after single dose (pooled immunogenicity of three lots of Vi-DT) II. Demonstrate the equivalence of immunogenicity as measured by anti-Vi IgG GMT of three lots of Vi-DT vaccine 4 weeks after single dose.

NCT ID: NCT03299426 Active, not recruiting - Typhoid Clinical Trials

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Start date: February 21, 2018
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy of a Typhoid conjugate vaccine (Vi-TCV) in Malawi, Africa among children age 9 months through 12 years. Participants will be randomized in a 1:1 ration to receive the study vaccine or the control vaccine (meningococcal group A conjugate vaccine - MCV-A).